The University of Illinois Cancer Center would like to make you aware of this funding opportunity from Cures Within Reach. Details below.

Cures Within Reach has an open Request for Proposals (RFP) for clinical repurposing trials in any blood cancer, with a preference for multiple myeloma and/or myelodysplastic syndrome.

Funder: Cures Within Reach

Letter of Intent Due: 07/29/2024 on ProposalCentral using the Disease Specific Repurposing Research program

RFP Highlights:

  • Eligible clinical trials must test approved drugs, devices, nutraceuticals, diagnostics and/or eligible cellular/gene therapies in a new indication
  • Proof of concept, Phase I or Phase IIA trials are preferred; we are also open to co-funding larger and/or ongoing trials to help speed patient impact
  • Budgets of up to $75,000 are accepted; this funding can cover all costs or supplement existing funding
  • There is no limit to the number of submissions from any one institution or PI
  • Top-rated LOI submissions will be invited to submit a full proposal
Translate »